FILE:CVH/CVH-8K-20080409154010.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported)
April 9, 2008 (April 8, 2008)
 
 
COVENTRY HEALTH CARE, INC.
(Exact name of registrant as specified in its charter).
 
 
 
6705 Rockledge Drive, Suite 900, Bethesda, Maryland 20817
(Address of principal executive offices) (Zip Code)
 
(301) 581-0600
(Registrant's telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
 
Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
 
Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
SECTION 5  CORPORATE GOVERNANCE AND MANAGEMENT
 
ITEM 5.02  Departure of Directors or Certain Officers
 
Tom McDonough, President of Coventry Health Care, Inc. ("the Company"), will retire from the Company effective July 1, 2008. Mr. McDonough joined the Company on April 1, 1998 and was highly instrumental in the building of our Company. In anticipation of the announced retirement, the Company had previously implemented a program of succession planning among all of its senior management. Accordingly, the Company's senior management reporting structure will be realigned to ensure the successful continuity of its business operations.
 
 
Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 


